Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126191571 | 12619157 | 1 | I | 20160720 | 20160803 | 20160803 | EXP | CA-AMGEN-CANSP2016090901 | CA-HQ SPECIALTY-CA-2016INT000661 | INTERCHEM | 33.00 | YR | F | Y | 0.00000 | 20160803 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126191571 | 12619157 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Unknown | 3.5714 MG (25 MG,1 IN 1 W) | U | 201749 | |||||||||
| 126191571 | 12619157 | 2 | SS | ENBREL | ETANERCEPT | 1 | Unknown | 7.1429 MG (50 MG, 1 IN 1 W) | U | 0 | |||||||||
| 126191571 | 12619157 | 3 | SS | CELEBREX | CELECOXIB | 1 | Unknown | UNK | U | 0 | |||||||||
| 126191571 | 12619157 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | 28.5714 MG (800 MG, 1 IN 4 W) | U | 0 | |||||||||
| 126191571 | 12619157 | 5 | SS | ASPIRIN. | ASPIRIN | 1 | Unknown | UNK | U | 0 | |||||||||
| 126191571 | 12619157 | 6 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 2.8571 MG (40 MG, 1 IN 2 W) | U | 0 | |||||||||
| 126191571 | 12619157 | 7 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | 20 MG, QD | U | 0 | 20 | MG | |||||||
| 126191571 | 12619157 | 8 | SS | SIMPONI | GOLIMUMAB | 1 | Unknown | 1.6667 MG (50 MG,1 IN 1 MO) | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126191571 | 12619157 | 1 | Rheumatoid arthritis |
| 126191571 | 12619157 | 2 | Rheumatoid arthritis |
| 126191571 | 12619157 | 3 | Arthritis |
| 126191571 | 12619157 | 4 | Rheumatoid arthritis |
| 126191571 | 12619157 | 5 | Product used for unknown indication |
| 126191571 | 12619157 | 6 | Rheumatoid arthritis |
| 126191571 | 12619157 | 7 | Rheumatoid arthritis |
| 126191571 | 12619157 | 8 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126191571 | 12619157 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126191571 | 12619157 | Drug effect decreased | |
| 126191571 | 12619157 | Drug effect incomplete | |
| 126191571 | 12619157 | Drug hypersensitivity | |
| 126191571 | 12619157 | Drug ineffective | |
| 126191571 | 12619157 | Pharyngeal oedema | |
| 126191571 | 12619157 | Rheumatoid arthritis | |
| 126191571 | 12619157 | Swelling face | |
| 126191571 | 12619157 | Swollen tongue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |